cancers Article Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence Kuan-Yang Chen 1,2,3, Yi-Hsiang Huang 1,4,* , Wan-Huai Teo 5, Ching-Wen Chang 5,6, Yu-Syuan Chen 5, Yi-Chen Yeh 7, Chieh-Ju Lee 4 and Jeng-Fan Lo 5,8,9,* 1 Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan;
[email protected] 2 Institute of Neuroscience, National Chengchi University, Taipei 11605, Taiwan 3 Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, Taipei 10629, Taiwan 4 Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan;
[email protected] 5 Institute of Oral Biology, National Yang-Ming University, Taipei 11221, Taiwan;
[email protected] (W.-H.T.); fl
[email protected] (C.-W.C.);
[email protected] (Y.-S.C.) 6 Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD 20892, USA 7 Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan;
[email protected] 8 Department of Dentistry, Taipei Veterans General Hospital, Taipei 11217, Taiwan 9 Cancer Progression Research Center, National Yang-Ming University, Taipei 11221, Taiwan * Correspondence:
[email protected] (Y.-H.H.); jfl
[email protected] (J.-F.L.); Tel.: +886-2-28712121 (ext. 7506) (Y.-H.H.); Fax: +886-2-28739318 (Y.-H.H.) Simple Summary: Tid1 acts as a tumor suppressor in various cancer types, however, its role in hepatocellular carcinoma (HCC) remains unclear.